Bristol-Myers all set to Buy Amylin for $5.3 Billion

Bristol-Myers

Bristol-Myers

According to the reports released late on Friday, Bristol-Myers Squibb Co (BMY) is planning to buy Amylin Pharmaceuticals Inc (AMLN), a biotechnology company, for nearly about 5.3 billion dollars cash price. This significant step taken by the Bristol-Myers Squibb Co will help in the extension of its portfolio in the treatment of diabetes through the addition of the drugs like Bydureon and Byetta. The Amylin Pharmaceuticals Inc is a diabetes therapy maker who is seeking the replacement of revenue from its best selling blood thinner that is facing a tough generic competition.

The Deal

According to reports, the transaction of the deal was approved unanimously by the board of directors of both the companies. Bristol-Myers revealed that with a follow on deal with AstraZeneca Plc (AZN), a UK based Pharmaceuticals Company; it has collaborated for the development of the products of Amylin once the deal is finalized. This deal will expand an ongoing partnership between these two pharmaceutical companies in the field of diabetes treatment. AstraZeneca has agreed on paying a cash sum of 3.4 billion dollars for the gaining of these rights. As per the statements made from the company officials, Bristol-Myers is going to pay either $31 per share cash or 10% premium to the closing price of Amylin on Friday. With the inclusion of the contractual payment obligation of Amilyn to Eli Lilly (LLY) and its net debt, the total valuation of the transaction of the deal sums up to about 7 billion dollars.

Collaboration between Bristol-Myers and AstraZeneca

The two famous pharmaceutical companies of AstraZeneca Plc and Bristol-Myers have already collaborated for their treatments on several types of diabetes like the Onglyza. Now they aim at further strengthening their position in this ever growing market worth multiple billions of dollars. There are more than 360 million people all over the world who have diabetes. An overwhelming majority of these people suffer from type 2 diabetes, which is a condition that can be accounted for the rising number of obese people in the different countries.

The chief executive of Bristol-Myers Lamberto Andreotti described in his statement that this deal is a unique way of building on their relationship with AstraZeneca. It demonstrates the innovative and sincere approach of Bristol-Myers to the development of partnerships and their business.

Approach of Amilyn

News reports released earlier this year based on the statements of the people well aware of the matter, stated that Amylin Pharmaceuticals Inc had begun approaching the potential buyers after their rejection of a bid made by Bristol-Myers itself. At that time the Bristol-Myers had made a takeover offer of 3.5 billion dollars which accounts to a mere $22 per share to Amilyn. But then Amilyn started facing pressure from Carl Icahn, an activist investor and hence began looking for new buyers. Five major pharmaceutical giants were in the line for the taking over of Amilyn including Sanofi SA, Novartis AG and also AstraZeneca. In the end the deal was finalized with New York based Pharmaceuticals Company Bristol-Myers Squibb Co (BMY) at a new revised rate of 5.3billion dollars.

Jay Raol

Leave a Reply

Your email address will not be published.

Recent Posts

Best Retirement Plans For Entrepreneurs While Inflation Soars

Best Retirement Plans For Entrepreneurs While Inflation Soars

As of 2021, over 150 million US workers identified themselves as self-employed. This means that they are responsible for their own retirement plans. Employees of big firms tend to
10 hours ago
Fashion Designer Vera Wang – The Fairy Godmother All Brides Want

Fashion Designer Vera Wang – The Fairy Godmother All Brides Want

Just shy of her 40th birthday, Vera Wang struggled to find a bridal gown that suited her taste. Her father pointed out her struggles for what they really were – a remarkable busi
10 hours ago
The Microsoft Employee Salary Hike: Peer Pressure In Tech

The Microsoft Employee Salary Hike: Peer Pressure In Tech

In the memo obtained by Geekwire, Nadella writes that he is aware of how much their talent is in demand. He appreciated their efforts in keeping the company running and thanked hi
15 hours ago
Grubhub Marketing: A Harsh Lesson in Disaster Management

Grubhub Marketing: A Harsh Lesson in Disaster Management

The GrubHub marketing disaster is a lesson in what not to do. Sure, even negative publicity is publicity. But sometimes, it leaves a bad taste in one’s mouth that is difficult to
1 day ago
Walmart Q1 Earnings 2022: Rising Inflation and Robust Sales Down Profits

Walmart Q1 Earnings 2022: Rising Inflation and Robust Sales Down Profits

In the Walmart earnings call 2022, Chief Financial Officer Brett Biggs mentioned that “Q1 profit declined more than expected with operating income down 20% and adjusted EPS down
1 day ago
Shareholders Reject Intel’s Executive Pay Package

Shareholders Reject Intel’s Executive Pay Package

The filing shows that “stockholders did not approve, on an advisory basis, Intel’s executive compensation of its listed officers.” The California-based tech company’s packa
3 days ago